Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
The Lancet. Haematology|December 28, 2020
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trialMarco Ladetto, Sergio Cortelazzo, Simone Ferrero, et al.Cancers|January 11, 2022
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Simone Ferrero, Eva Hoster, et al.Blood Advances|January 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trialSimone Ragaini, Anna Galli, Elisa Genuardi, et al.Advances in Hematology|February 7, 2022
Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb StudyMario Petrini, Gianluca Gaidano, Andrea Mengarelli, et al.Leukemia|November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trialMouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.Haematologica|September 21, 2019
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Davide Rossi, Andrea Rinaldi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2021
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 StudyStefano Luminari, Martina Manni, Sara Galimberti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2017
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell LymphomasSergio Cortelazzo, Corrado Tarella, Alessandro Massimo Gianni, et al.British Journal of Haematology|May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53)Miguel Bastos-Boente, Alejandro Medina-Herrera, Almudena Navarro-Bailón, et al.Pageof 14